Scar endometriosis is an infrequent type of extrapelvic endometriosis that is rather close together with obstetrical and gynecological surgeries. It is mostly confused with other dermatological or surgical conditions and delays the diagnosis. We report a case of a 50-year-old woman presenting with scar endometriosis 23 years after her last lower segment caesarean section. The epidemiology, diagnosis, pathogenesis, and treatment of the situation are discussed.
Amaç: Çalışmamızda 2005-2012 yılları arasındaki sezaryenlerin yıllara göre dağılımını, sezaryen endikasyonlarını ve epidemiyolojik değişimleri karşı-laştırarak, geleceğe yönelik yapılması gerekenleri tartışmak amaçlanmıştır.Yöntemler: İstanbul Eğitim Araştırma Hastanesi Kadın Hastalıkları ve Doğum Kliniği'nde 2005-2012 yılları arasındaki 10499 doğum içinden sezaryen uygulanan 4137 hastanın dosyaları retrospektif olarak incelendi. Yılla-ra göre sezaryenle doğum yapmış hastalar sezaryen endikasyonlarına, yaş gruplarına, gebelik haftalarına, doğum ağırlıklarına, bebek cinsiyetlerine, sezaryende tercih edilen anestezi türüne ve sezaryenin normal doğuma oranlarına göre yıllık bazda değerlendirildi ve karşılaştırıldı. Results: Cesarean section was performed for 32.5% and 40.1% patients in 2005 and 2012, respectively. The main indications were previous uterine surgery (44.5%), fetal distress (18.3%) and cephalopelvic disproportion (33.7%). There was no statistical difference in terms of gravida, parity, anesthesia, and birth weight in either year. However, cesarean rates were significantly increased in the last four years of the study period in comparison with the first four years. Conclusion:Rates of caesarean section are increasing. To counteract this trend, patients should be informed about the benefits of vaginal delivery and be encouraged to attempt vaginal delivery after cesarean section now that the skills of staff in delivery clinics are improving. Clinicians and patients must be aware of side effects of elective cesarean sections. Pain management during delivery may be considered as a means of reversing the increasing cesarean rates.
Objective: In this study, we investigate the effects of maternal body mass index (BMI), weight gain during pregnancy, delivery stage, amount of amniotic fluid, and amniotic membrane status on the calculation of estimated fetal weight. pregnant women who gave birth in our hospital were reviewed. From records, demographic data of patients, maternal BMI (kg/m 2 ), weight gain during pregnancy, delivery stage, amniotic fluid volume and amniotic membrane status, mode of delivery, ultrasound-estimated fetal weight, and the actual birth weight of the newborn have been reviewed.Results: Birth weight of fetuses estimated by sonography was in the range of 2680-4345 g with an average of 3467.33±417.30 g. The actual birth weight of the newborns was 3468±383.99 g with an average of 2600-4550 g. With ultrasound-estimated fetal weight and the actual birth weight with error range of ±10%, 76% correct prediction rate (n=76) found. When considering maternal parity, stage of labor (latent phase-active phase), sex of the fetus, preconceptional BMI, and maternal weight gain during pregnancy, there is no statistically significant effect (p<0.05) of these factors on the accuracy of the estimated fetal weight. Decreased amniotic fluid and/or rupture of amniotic membranes in pregnant women ultrasound-estimated fetal weight was closer correlation to the actual birth. Conclusion:The correct prediction of fetal weight is of great importance because of the potential risk estimation for the mother and newborn and in deciding the mode of delivery. Therefore, variables that affect the probability of errors in ultrasonographic measurements should be considered in advance, and if necessary, measures should be planned again MethodsThe files of pregnant women applying to our clinic and giving birth between January 2012 and January 2013 were screened. One hundred pregnant women for whom estimated fetal weight measurement was performed using obstetric ultrasonography (USG) and who were 37-42 weeks according to the last menstrual period, singular, alive, and at head presentation were included in the study. Cases with fetal anomalies, multiple pregnancies, dead fetuses, and cases in which detailed fetal biometric measurements cannot be performed because of obstetric emergencies
To evaluate whether body mass index (BMI) is an important parameter that affects the thickness of the endometrium in asymptomatic postmenopausal women. Methods: Our study was performed retrospectively using computer and file records of 434 postmenopausal women who were admitted to the Istanbul Research and Training Hospital Menopause clinic between June 2008 and April 2010. Endometrial thickness and biopsy results were compared among patients with endometrial thickness of >5 mm. The correlation between endometrial thickness and menopause age, BMI, diabetes mellitus (DM), hypertension (HT), and smoking were evaluated statistically. Results: Statistically significant p-values were obtained between endometrial thickness and high BMI, DM, HT, and menopause age. Evaluation of the pathology results revealed atypical complex hyperplasia in one case (0.2%), endometrial polyp in 22 cases (5.1%), endometrial proliferation in 17 cases (3.9%), simple endometrial hyperplasia in four cases (0.9%), atrophic endometrium in 22 cases (5.1%), and endometrial secretion in 12 cases (2.8%). Conclusion: We were determined that BMI is an important parameter that affects endometrial thickness and should be considered in follow-ups of endometrial pathologies of asymptomatic postmenopausal women.
Amaç: Jinekolojik maligniteli hastalarda peritoneal implant saptamada rutin abdominal MRG, diffüzyon ağırlıklı görüntüler (DAG) ve PET-BT tetkiklerinin duyarlılıklarını saptamak ve birbirleri ile karşılaştırmaktır. Gereç ve
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.